Triple Agonist 30mg — Verification Report
From Modern Research Peptides · Lot CN41689TH · Tested August 2026
VialTalk
Triple Agonist 30mg
Modern Research Peptides
Score
106.5
Grade
A++
Superlative
Lot CN41689TH
Tested August 2026
Report ID
e750b9ff
Test
Method
Result
Status
PurityFull credit
HPLC
99.93%
Full credit
IdentityFull credit
Mass spectrometry
Confirmed
Full credit
ContentFull credit
Gravimetric vs label claim
30 mg labeled · 30.56 mg tested
Full credit
EndotoxinFull credit
USP <85> compendial
Screened
Full credit
Heavy metalsFull credit
USP <232>/<233> compendial
Screened
Full credit
SterilityPartial
PCR / DNA microarray
Screened
Partial
Batch conformityPartial
Two-batch average
Assessed
Partial
Additional screens, not scoredFentanyl screen
Verified against the submitted certificate. VialTalk received this vendor's certificate, checked each test against the reported method, and scored it under a published methodology. Tests the vendor did not submit are listed above rather than omitted. Scores above 100 reflect laboratory credibility weighting.
This report is issued by VialTalk. It is not a laboratory certificate.Scoring methodology →
Canonical source: https://vialtalk.com/vendors/modern-research-peptides/coas/e750b9ff-8919-4d81-8a9a-fd3c49350db1